19 May 2013
Keywords: gilead, sciences, boosted, tenefovir, df, resistance, data
Article | 25 October 2000
Gilead Sciences has presented new data showing that its investigationalanti-HIV drug tenefovir DF is effective in reducing viral load in ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.